Chemodex

Procyanidin B2

CHF 64.00
In stock
CDX-P0591-M0011 mgCHF 64.00
More Information
Product Details
Synonyms (-)-Epicatechin (4β-8)-(-)-epicatechin; 4,8?-Bi-[(+)-epicatechin]; cis,cis?-4,8?-Bi-(3,3?,4?,5,7-pentahydroxy-flavan); Proanthocyanidin B2; Procyanidol B2
Product Type Chemical
Properties
Formula

C30H26O12

MW 578.52
CAS 29106-49-8
Source/Host Chemicals Isolated from plant.
Purity Chemicals ≥90% (HPLC)
Appearance Light beige/brown to beige/brown powder.
Solubility Soluble in DMSO, ethanol, DMF (all 30mg/ml) or water (10mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key XFZJEEAOWLFHDH-NFJBMHMQSA-N
Smiles O[C@@H]1[C@@H](C2=C3C(C[C@@H](O)[C@@H](C4=CC(O)=C(O)C=C4)O3)=C(O)C=C2O)C5=C(O)C=C(O)C=C5O[C@@H]1C6=CC(O)=C(O)C=C6
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Procyanidin B2, one of the most representative naturally occurring edible pigments, is usually isolated from the seeds, fruits and leaves of lots of common plants, such as grapes or apples. Procyanidin B2 has numerous bioactivities, including anti-inflammatory, anti-oxidative stress, neuroprotective, lipid metabolism regulating, wound healing, anti-diabetic, metabolic syndrome regulating, anti-atherosclerotic, anti-adipogenesis, anti-viral and anti-cancer properties. Procyanidin B2 targets and mediates several signaling pathways like NF-κB, MAPK, PI3K/Akt, NLRP3, apoptotic axis, VEGF/VEGFR2, PPARγ and Nrf-2/HO-1. Procyanidin B2 possesses the potential to treat/prevent a wide range of human diseases, such as diabetes mellitus, diabetic complications, atherosclerosis, cancers and non-alcoholic fatty liver disease.

Product References

(1) M.M. Avelar & C.M.C.P. Gouvea; Indian J. Pharm. Sci. 74, 351 (2012) | (2) H. Yang, et al.; Biochem. Pharmacol. 92, 599 (2014) | (3) T.C. Sutcliffe, et al.; Antioxidants 6, 77 (2017) | (4) S. Gopalakrishnan, et al.; IUBMB Life 70, 445 (2018) | (5) J. Feng, et al.; J. Cell. Mol. Med. 23, 6479 (2019) | (6) Y. Tian, et al.; Front. Immunol. 10, 1895 (2019) | (7) X. Zhu, et al.; Antioxid. Redox Signal. 35, 75 (2021) | (8) L. Liu, et al.; Pharmacol. Res. 177, 106127 (2022) | (9) M. Xu, et al.; Anim. Biotechnol. 33, 346 (2022) | (10) Q. Sun, et al.; Bioengineered 13, 6500 (2022) | (11) J. Liu, et al.; Nutrients 14, 1756 (2022) | (12) J. Zhao, et al.; Cell Death Dis. 13, 594 (2022) | (13) H. Wang, et al.; Int. J. Mol. Sci. 23, 7769 (2022) | (14) W. Cai, et al.; Int. Immunopharmacol. 113, 109336 (2022) | (15) Y.P. Zou, et al.; J. Orthop. Res. 41, 1555 (2023) | J. Chen, et al.; Food Chem. 420, 136101 (2023)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.